Hypothalamic syndrome
Open accessAbstract
Hypothalamic syndrome (HS) is a rare disorder caused by disease-related and/or treatment-related injury to the hypothalamus, most commonly associated with rare, non-cancerous parasellar masses, such as craniopharyngiomas, germ cell tumours, gliomas, cysts of Rathke's pouch and Langerhans cell histiocytosis, as well as with genetic neurodevelopmental syndromes, such as Prader-Willi syndrome and septo-optic dysplasia. HS is characterized by intractable weight gain associated with severe morbid obesity, multiple endocrine abnormalities and memory impairment, attention deficit and reduced impulse control as well as increased risk of cardiovascular and metabolic disorders. Currently, there is no cure for this condition but treatments for general obesity are often used in patients with HS, including surgery, medication and counselling. However, these are mostly ineffective and no medications that are specifically approved for the treatment of HS are available. Specific challenges in HS are because the syndrome represents an adverse effect of different diseases, and that diagnostic criteria, aetiology, pathogenesis and management of HS are not completely defined.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Other tumors, such as low-grade gliomas and germinomas, also confer increased risk of acquired hypothalamic syndrome.
“As previously summarized, craniopharyngioma is the prototypic suprasellar tumor leading to acquired hypothalamic syndrome, but other tumors (eg, low-grade gliomas, germinomas) also confer increased risk.”
From Approach to the patient with acquired hypothalamic syndrome (2026) · cites this paper as [2]
Injury to the hypothalamus, whether from tumors affecting this brain area or their treatment, leads to acquired hypothalamic syndrome in approximately 80% of individuals, depending in large part on tumor characteristics.
“Injury to the hypothalamus, whether from the tumors affecting this brain area or their treatment, leads to acquired hypothalamic syndrome in approximately 80% of individuals, depending in large part on the tumor characteristics (1, 2).”
From Approach to the patient with acquired hypothalamic syndrome (2026) · cites this paper as [2]
Other highly morbid symptoms of hypothalamic syndrome include abnormal sleep and circadian function, temperature dysregulation, and behavior changes.
“Clinicians caring for such patients have also appreciated the presence of other highly morbid symptoms, including abnormal sleep and circadian function, temperature dysregulation, and behavior changes (2).”
From Approach to the patient with acquired hypothalamic syndrome (2026) · cites this paper as [2]
Craniopharyngioma is the prototypic suprasellar tumor leading to acquired hypothalamic syndrome.
“As previously summarized, craniopharyngioma is the prototypic suprasellar tumor leading to acquired hypothalamic syndrome, but other tumors (eg, low-grade gliomas, germinomas) also confer increased risk.”
From Approach to the patient with acquired hypothalamic syndrome (2026) · cites this paper as [2]
Cites
Hormonal Replacement in Hypopituitarism in Adults: An Endocrine Society Clinical Practice Guideline
Fleseriu, M., Hashim, I. A., Karavitaki, N., Melmed, S., Murad, M. H., Salvatori, R., & Samuels, M. H. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-2118 · Cited by 945 · see citing works
Role of Melatonin in the Regulation of Human Circadian Rhythms and Sleep
Cajochen, C., Kräuchi, K., & Wirz‐Justice, A. (2003) · Journal of Neuroendocrinology · doi:10.1046/j.1365-2826.2003.00989.x · Cited by 735 · see citing works
The Lancet Psychiatry Commission on psychological treatments research in tomorrow's science
Holmes, E. A., Ghaderi, A., Harmer, C. J., Ramchandani, P. G., Cuijpers, P., Morrison, A. P., Roiser, J. P., Bockting, C. L. H., O'Connor, R. C., Shafran, R., et al. (2018) · The Lancet Psychiatry · doi:10.1016/s2215-0366(17)30513-8 · Cited by 624 · see citing works
The anatomy of apathy: a neurocognitive framework for amotivated behaviour
Le Heron, C., Apps., M. A. J., & Husain, M. (2018) · Neuropsychologia · doi:10.1016/j.neuropsychologia.2017.07.003 · Cited by 380 · see citing works
The impact of sleep deprivation on food desire in the human brain
Greer, S. M., Goldstein, A. N., & Walker, M. P. (2013) · Nature Communications · doi:10.1038/ncomms3259 · Cited by 375 · see citing works
Minireview: Inflammation and Obesity Pathogenesis: The Hypothalamus Heats Up
Thaler, J. P., & Schwartz, M. W. (2010) · Endocrinology · doi:10.1210/en.2010-0336 · Cited by 313 · see citing works
BERTHOUD, H. R., & JEANRENAUD, B. (1979) · Endocrinology · doi:10.1210/endo-105-1-146 · Cited by 266 · see citing works
Harz, K. J., Müller, H. L., Waldeck, E., Pudel, V., & Roth, C. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021797 · Cited by 214 · see citing works
Self-citationNeural Mechanisms Underlying Hyperphagia in Prader‐Willi Syndrome
Holsen, L. M., Zarcone, J. R., Brooks, W. M., Butler, M. G., Thompson, T. I., Ahluwalia, J. S., Nollen, N. L., & Savage, C. R. (2006) · Obesity · doi:10.1038/oby.2006.118 · Cited by 189 · see citing works
Burman, P., Mattsson, A. F., Johannsson, G., Höybye, C., Holmer, H., Dahlqvist, P., Berinder, K., Engström, B. E., Ekman, B., Erfurth, E. M., et al. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-4059 · Cited by 184 · see citing works
An amygdala-to-hypothalamus circuit for social reward
Hu, R. K., Zuo, Y., Ly, T., Wang, J., Meera, P., Wu, Y. E., & Hong, W. (2021) · Nature Neuroscience · doi:10.1038/s41593-021-00828-2 · Cited by 174 · see citing works
A double-blind randomized controlled trial of oxytocin nasal spray in Prader Willi syndrome
Einfeld, S. L., Smith, E., McGregor, I. S., Steinbeck, K., Taffe, J., Rice, L. J., Horstead, S. K., Rogers, N., Hodge, M. A., & Guastella, A. J. (2014) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.36653 · Cited by 131 · see citing works
Tauber, M., Mantoulan, C., Copet, P., Jauregui, J., Demeer, G., Diene, G., Rogé, B., Laurier, V., Ehlinger, V., Arnaud, C., et al. (2011) · Orphanet Journal of Rare Diseases · doi:10.1186/1750-1172-6-47 · Cited by 117 · see citing works
Self-citationBrauner, R., Serreau, R., Souberbielle, J.-C., Pouillot, M., Grouazel, S., Recasens, C., Zerah, M., Sainte-Rose, C., & Treluyer, J.-M. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-2126 · Cited by 37 · see citing works
Perez, F. A., Elfers, C., Yanovski, J. A., Shoemaker, A. H., Abuzzahab, M. J., & Roth, C. L. (2021) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.14366 · Cited by 29 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
van Roessel, I. M. A. A., Hulsmann, S. C., Schouten-van Meeteren, A. Y. N., Hoving, E. W., Janssens, G. O., Raphael, M. F., Zijtregtop-Blom, E. A. M., de Vos-Kerkhof, E., Bakker, B., Tissing, W. J. E., et al. (2025) · eClinicalMedicine · doi:10.1016/j.eclinm.2025.103313 · Cited by 10 · see citing works
Approach to the patient with acquired hypothalamic syndrome
Grishman, E. K., & McCormack, S. E. (2026) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgag197
- Authors
- Müller, H. L., Tauber, M., Lawson, E. A., Özyurt, J., Bison, B., Martinez-Barbera, J.-P., Puget, S., Merchant, T. E., & van Santen, H. M.
- Affiliations
- Centre National de la Recherche Scientifique (FR)
- Harvard University (US)
- Carl von Ossietzky Universität Oldenburg (DE)
- University Hospital Augsburg (DE)
- St. Jude Children's Research Hospital (US)
- ORCID
- Venue
- Nature Reviews Disease Primers
- Published
- 2022-04-21
- Volume
- 8
- Issue
- 1
- Pages
- 24-24
- ISSN
- 2056-676X (ISSN-L)
- OpenAlex
- W4224262686
- Cited by
- 144
- References
- 15
- Citations by year
- 2026: 27 · 2025: 48 · 2024: 31 · 2023: 24 · 2022: 13 · 2021: 1
- FWCI
- 4.12
- Type
- journal article
- Language
- en
- Open access
- green
- dspace.library.uu.nl
- Licence
- Locations
- Nature Reviews Disease Primers (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- Utrecht University Repository (Utrecht University) (submittedVersion, other-oa)
- UCL Discovery (University College London) (submittedVersion)
- OPUS (Augsburg University) (submittedVersion)
- Funders
- Cancer Research UK (27727)
- CHILDREN with CANCER UK (15/190)
- Brain Tumour Charity (GN-000382)
- Medical Research Council (MR/M000125/1)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
- Health Sciences › Medicine › Reproductive Medicine › Hypothalamic control of reproductive hormones
- Keywords
- hypothalamic syndrome, hypothalamic injury, morbid obesity, craniopharyngioma, germ cell tumors, Langerhans cell histiocytosis, Prader-Willi syndrome, septo-optic dysplasia, endocrine disorders, memory impairment, obesity treatment, pathophysiology, diagnosis, prevention
- MeSH terms
- Craniopharyngioma, Endocrine System Diseases, Humans, Hypothalamus, Pituitary Neoplasms, Prader-Willi Syndrome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review